Regeneration of the Corneal Endothelium

References

• Nishida T, Saika S. Cornea and Sclera: anatomy and physiology. Cornea. 3rd edn. 2011;1:3–24.
   Google Scholar
• Joyce NC. Proliferative capacity of corneal endothelial cells. Exp Eye Res. 2012;95(1):16–23. doi:10.1016/j.exer.2011.08.014.
   PubMed Web of Science ®Google Scholar
• Tan DT, Dart JK, Holland EJ, Kinoshita S. Corneal transplantation. Lancet. 2012;379(9827):1749–61. doi:10.1016/S0140-6736(12)60437-1.
   PubMed Web of Science ®Google Scholar
• Melles GR, Eggink FA, Lander F, Pels E, Rietveld FJ, Beekhuis WH, Binder PS. A surgical technique for posterior lamellar keratoplasty. Cornea. 1998;17(6):618–26. doi:10.1097/00003226-199811000-00010.
   PubMed Web of Science ®Google Scholar
• Melles GR, Lander F, Nieuwendaal C. Sutureless, posterior lamellar keratoplasty: a case report of a modified technique. Cornea. 2002;21(3):325–27. doi:10.1097/00003226-200204000-00018.
   PubMed Web of Science ®Google Scholar
• Melles GR, Wijdh RH, Nieuwendaal CP. A technique to excise the descemet membrane from a recipient cornea (descemetorhexis). Cornea. 2004;23(3):286–88. doi:10.1097/00003226-200404000-00011.
   PubMed Web of Science ®Google Scholar
• Price FW Jr., Price MO. Descemet’s stripping with endothelial keratoplasty in 50 eyes: a refractive neutral corneal transplant. J Refract Surg. 2005;21(4):339–45. doi:10.3928/1081-597X-20050701-07.
   PubMed Web of Science ®Google Scholar
• Gorovoy MS. Descemet-stripping automated endothelial keratoplasty. Cornea. 2006;25(8):886–89. doi:10.1097/01.ico.0000214224.90743.01.
   PubMed Web of Science ®Google Scholar
• Price MO, Price FW Jr. Endothelial cell loss after descemet stripping with endothelial keratoplasty influencing factors and 2-year trend. Ophthalmology. 2008;115(5):857–65. doi:10.1016/j.ophtha.2007.06.033.
   PubMed Web of Science ®Google Scholar
• Terry MA, Shamie N, Chen ES, Phillips PM, Shah AK, Hoar KL, Friend DJ. Endothelial keratoplasty for Fuchs’ dystrophy with cataract: complications and clinical results with the new triple procedure. Ophthalmology. 2009;116(4):631–39. doi:10.1016/j.ophtha.2008.11.004.
   PubMed Web of Science ®Google Scholar
• Dapena I, Ham L, Melles GR. Endothelial keratoplasty: DSEK/DSAEK or DMEK–the thinner the better? Curr Opin Ophthalmol. 2009;20(4):299–307. doi:10.1097/ICU.0b013e32832b8d18.
   PubMed Web of Science ®Google Scholar
• Ham L, Dapena I, van Luijk C, van der Wees J, Melles GR. Descemet membrane endothelial keratoplasty (DMEK) for Fuchs endothelial dystrophy: review of the first 50 consecutive cases. Eye (Lond). 2009;23(10):1990–98. doi:10.1038/eye.2008.393.
   PubMed Web of Science ®Google Scholar
• Ham L, van Luijk C, Dapena I, Wong TH, Birbal R, van der Wees J, Melles GR. Endothelial cell density after descemet membrane endothelial keratoplasty: 1- to 2-year follow-up. Am J Ophthalmol. 2009;148(4):521–27. doi:10.1016/j.ajo.2009.04.025.
   PubMed Web of Science ®Google Scholar
• Baratz KH, McLaren JW, Maguire LJ, Patel SV. Corneal haze determined by confocal microscopy 2 years after Descemet stripping with endothelial keratoplasty for Fuchs corneal dystrophy. Arch Ophthalmol. 2012;130(7):868–74. doi:10.1001/archophthalmol.2012.73.
   PubMedGoogle Scholar
• Patel SV. Graft survival and endothelial outcomes in the new era of endothelial keratoplasty. Exp Eye Res. 2012;95(1):40–47. doi:10.1016/j.exer.2011.05.013.
   PubMed Web of Science ®Google Scholar
• Tourtas T, Laaser K, Bachmann BO, Cursiefen C, Kruse FE. Descemet membrane endothelial keratoplasty versus Descemet stripping automated endothelial keratoplasty. Am J Ophthalmol. 2012;153(6):1082–1090 e1082. doi:10.1016/j.ajo.2011.12.012.
   PubMed Web of Science ®Google Scholar
• Kruse FE, Schrehardt US, Tourtas T. Optimizing outcomes with Descemetʼs membrane endothelial keratoplasty. Curr Opin Ophthalmol. 2014;25(4):325–34. doi:10.1097/ICU.0000000000000072.
   PubMed Web of Science ®Google Scholar
• Hamzaoglu EC, Straiko MD, Mayko ZM, Sales CS, Terry MA. The first 100 eyes of standardized descemet stripping automated endothelial keratoplasty versus standardized descemet membrane endothelial keratoplasty. Ophthalmology. 2015;122(11):2193–99. doi:10.1016/j.ophtha.2015.07.003.
   PubMed Web of Science ®Google Scholar
• Singh A, Zarei-Ghanavati M, Avadhanam V, Liu C. Systematic review and meta-analysis of clinical outcomes of descemet membrane endothelial keratoplasty versus descemet stripping endothelial keratoplasty/descemet stripping automated endothelial keratoplasty. Cornea. 2017;36(11):1437–43. doi:10.1097/ICO.0000000000001320.
   PubMed Web of Science ®Google Scholar
• Brockmann T, Brockmann C, Maier A-K, Schroeter J, Pleyer U, Bertelmann E, Joussen AM, Torun N. Clinicopathology of graft detachment after Descemet’s membrane endothelial keratoplasty. Acta Ophthalmol. 2014;92(7):e556–561. doi:10.1111/aos.12419.
   PubMed Web of Science ®Google Scholar
• Brockmann T, Brockmann C, Maier A-K, Gundlach E, Schroeter J, Bertelmann E, Joussen AM, Torun N. Descemet membrane endothelial keratoplasty for graft failure after descemet stripping endothelial keratoplasty: clinical results and histopathologic findings. JAMA Ophthalmol. 2015;133(7):813–19. doi:10.1001/jamaophthalmol.2015.0906.
   PubMed Web of Science ®Google Scholar
• Gain P, Jullienne R, He Z, Aldossary M, Acquart S, Cognasse F, Thuret G. Global survey of corneal transplantation and eye banking. JAMA Ophthalmol. 2016;134(2):167–73. doi:10.1001/jamaophthalmol.2015.4776.
   PubMed Web of Science ®Google Scholar
• Deng SX, Lee WB, Hammersmith KM, Kuo AN, Li JY, Shen JF, Weikert MP, Shtein RM. Descemet membrane endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology. Ophthalmology. 2018;125(2):295–310. doi:10.1016/j.ophtha.2017.08.015.
   PubMed Web of Science ®Google Scholar
• Brockmann T, Pilger D, Brockmann C, Maier AKB, Bertelmann E, Torun N. Predictive factors for clinical outcomes after primary descemet’s membrane endothelial keratoplasty for Fuchs’ endothelial dystrophy. Curr Eye Res. 2019;44(2):147–53. doi:10.1080/02713683.2018.1538459.
   PubMed Web of Science ®Google Scholar
• Kinoshita S, Koizumi N, Ueno M, Okumura N, Imai K, Tanaka H, Yamamoto Y, Nakamura T, Inatomi T, Bush J, et al. Injection of cultured cells with a ROCK inhibitor for bullous keratopathy. N Engl J Med. 2018;378:995–1003. doi:10.1056/NEJMoa1712770.
   PubMed Web of Science ®Google Scholar
• Jumblatt MM, Maurice DM, McCulley JP. Transplantation of tissue-cultured corneal endothelium. Invest Ophthalmol Vis Sci. 1978;17:1135–41.
   PubMed Web of Science ®Google Scholar
• Gospodarowicz D, Greenburg G, Alvarado J. Transplantation of cultured bovine corneal endothelial cells to rabbit cornea: clinical implications for human studies. Proc Natl Acad Sci U S A. 1979;76(1):464–68. doi:10.1073/pnas.76.1.464.
   PubMed Web of Science ®Google Scholar
• Ishino Y, Sano Y, Nakamura T, Connon CJ, Rigby H, Fullwood NJ, Kinoshita S. Amniotic membrane as a carrier for cultivated human corneal endothelial cell transplantation. Invest Ophthalmol Vis Sci. 2004;45(3):800–06. doi:10.1167/iovs.03-0016.
   PubMed Web of Science ®Google Scholar
• Sumide T, Nishida K, Yamato M, Ide T, Hayashida Y, Watanabe K, Yang J, Kohno C, Kikuchi A, Maeda N, et al. Functional human corneal endothelial cell sheets harvested from temperature-responsive culture surfaces. Faseb J. 2006;20(2):392–94. doi:10.1096/fj.04-3035fje.
   PubMed Web of Science ®Google Scholar
• Hitani K, Yokoo S, Honda N, Usui T, Yamagami S, Amano S. Transplantation of a sheet of human corneal endothelial cell in a rabbit model. Mol Vis. 2008;14:1–9.
   PubMed Web of Science ®Google Scholar
• Eye Bank Association of America (EBAA). Eye Banking Statistical Report. Washington, DC; 2018.
   Google Scholar
• Yoshida J, Yokoo S, Oshikata-Miyazaki A, Amano S, Takezawa T, Yamagami S. Transplantation of human corneal endothelial cells cultured on bio-engineered collagen vitrigel in a rabbit model of corneal endothelial dysfunction. Curr Eye Res. 2017;42(11):1420–25. doi:10.1080/02713683.2017.1351568.
   PubMed Web of Science ®Google Scholar
• Mimura T, Yamagami S, Yokoo S, Usui T, Tanaka K, Hattori S, Irie S, Miyata K, Araie M, Amano S. Cultured human corneal endothelial cell transplantation with a collagen sheet in a rabbit model. Invest Ophthalmol Vis Sci. 2004;45(9):2992–97. doi:10.1167/iovs.03-1174.
   PubMed Web of Science ®Google Scholar
• Koizumi N, Sakamoto Y, Okumura N, Okahara N, Tsuchiya H, Torii R, Cooper LJ, Ban Y, Tanioka H, Kinoshita S. Cultivated corneal endothelial cell sheet transplantation in a primate model. Invest Ophthalmol Vis Sci. 2007;48(10):4519–26. doi:10.1167/iovs.07-0567.
   PubMed Web of Science ®Google Scholar
• Koizumi N, Okumura N, Kinoshita S. Development of new therapeutic modalities for corneal endothelial disease focused on the proliferation of corneal endothelial cells using animal models. Exp Eye Res. 2012;95(1):60–67. doi:10.1016/j.exer.2011.10.014.
   PubMed Web of Science ®Google Scholar
• Peh GSL, Ang H-P, Lwin CN, Adnan K, George BL, Seah X-Y, Lin S-J, Bhogal M, Liu Y-C, Tan DT, et al. Regulatory compliant tissue-engineered human corneal endothelial grafts restore corneal function of rabbits with bullous keratopathy. Sci Rep. 2017;7(1):14149. doi:10.1038/s41598-017-14723-z.
   PubMed Web of Science ®Google Scholar
• Peh GSL, Ong HS, Adnan K, Ang H-P, Lwin CN, Seah X-Y, Lin S-J, Mehta JS. Functional evaluation of two corneal endothelial cell-based therapies: tissue-engineered construct and cell injection. Sci Rep. 2019;9(1):6087. doi:10.1038/s41598-019-42493-3.
   PubMed Web of Science ®Google Scholar
• Wang T-J, Wang I-J, Lu J-N, Young T-H. Novel chitosan-polycaprolactone blends as potential scaffold and carrier for corneal endothelial transplantation. Mol Vis. 2012;18:255–64.
   PubMed Web of Science ®Google Scholar
• Kimoto M, Shima N, Yamaguchi M, Hiraoka Y, Amano S, Yamagami S. Development of a bioengineered corneal endothelial cell sheet to fit the corneal curvature. Invest Ophthalmol Vis Sci. 2014;55(4):2337–43. doi:10.1167/iovs.13-13167.
   PubMed Web of Science ®Google Scholar
• Rizwan M, Peh GSL, Ang H-P, Lwin NC, Adnan K, Mehta JS, Tan WS, Yim EKF. Sequentially-crosslinked bioactive hydrogels as nano-patterned substrates with customizable stiffness and degradation for corneal tissue engineering applications. Biomaterials. 2017;120:139–54. doi:10.1016/j.biomaterials.2016.12.026.
   PubMed Web of Science ®Google Scholar
• Mimura T, Shimomura N, Usui T, Noda Y, Kaji Y, Yamgami S, Amano S, Miyata K, Araie M. Magnetic attraction of iron-endocytosed corneal endothelial cells to Descemet’s membrane. Exp Eye Res. 2003;76(6):745–51. doi:10.1016/S0014-4835(03)00057-5.
   PubMed Web of Science ®Google Scholar
• Mimura T, Yamagami S, Usui T, Ishii Y, Ono K, Yokoo S, Funatsu H, Araie M, Amano S. Long-term outcome of iron-endocytosing cultured corneal endothelial cell transplantation with magnetic attraction. Exp Eye Res. 2005;80(2):149–57. doi:10.1016/j.exer.2004.08.021.
   PubMed Web of Science ®Google Scholar
• Patel SV, Bachman LA, Hann CR, Bahler CK, Fautsch MP. Human corneal endothelial cell transplantation in a human ex vivo model. Invest Ophthalmol Vis Sci. 2009;50(5):2123–31. doi:10.1167/iovs.08-2653.
   PubMed Web of Science ®Google Scholar
• Moysidis SN, Alvarez-Delfin K, Peschansky VJ, Salero E, Weisman AD, Bartakova A, Raffa GA, Merkhofer RM Jr., Kador KE, Kunzevitzky NJ, et al. Magnetic field-guided cell delivery with nanoparticle-loaded human corneal endothelial cells. Nanomedicine. 2015;11(3):499–509. doi:10.1016/j.nano.2014.12.002.
   PubMed Web of Science ®Google Scholar
• Xia X, Atkins M, Dalal R, Kuzmenko O, Chang K-C, Sun CB, Benatti CA, Rak DJ, Nahmou M, Kunzevitzky NJ, et al. Magnetic human corneal endothelial cell transplant: delivery, retention, and short-term efficacy. Invest Ophthalmol Vis Sci. 2019;60(7):2438–48. doi:10.1167/iovs.18-26001.
   PubMed Web of Science ®Google Scholar
• Yokoo S, Yamagami S, Yanagi Y, Uchida S, Mimura T, Usui T, Amano S. Human corneal endothelial cell precursors isolated by sphere-forming assay. Invest Ophthalmol Vis Sci. 2005;46(5):1626–31. doi:10.1167/iovs.04-1263.
   PubMed Web of Science ®Google Scholar
• Yamagami S, Yokoo S, Mimura T, Takato T, Araie M, Amano S. Distribution of precursors in human corneal stromal cells and endothelial cells. Ophthalmology. 2007;114(3):433–39. doi:10.1016/j.ophtha.2006.07.042.
   PubMed Web of Science ®Google Scholar
• Mimura T, Yokoo S, Araie M, Amano S, Yamagami S. Treatment of rabbit bullous keratopathy with precursors derived from cultured human corneal endothelium. Invest Ophthalmol Vis Sci. 2005;46(10):3637–44. doi:10.1167/iovs.05-0462.
   PubMed Web of Science ®Google Scholar
• Mimura T, Yamagami S, Yokoo S, Yanagi Y, Usui T, Ono K, Araie M, Amano S. Sphere therapy for corneal endothelium deficiency in a rabbit model. Invest Ophthalmol Vis Sci. 2005;46(9):3128–35. doi:10.1167/iovs.05-0251.
   PubMed Web of Science ®Google Scholar
• Mimura T, Yamagami S, Usui T, Seiichi S, Honda N, Amano S. Necessary prone position time for human corneal endothelial precursor transplantation in a rabbit endothelial deficiency model. Curr Eye Res. 2007;32(7–8):617–23. doi:10.1080/02713680701530589.
   PubMed Web of Science ®Google Scholar
• Okumura N, Koizumi N, Ueno M, Sakamoto Y, Takahashi H, Tsuchiya H, Hamuro J, Kinoshita S. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue. Am J Pathol. 2012;181(1):268–77. doi:10.1016/j.ajpath.2012.03.033.
   PubMed Web of Science ®Google Scholar
• Okumura N, Sakamoto Y, Fujii K, Kitano J, Nakano S, Tsujimoto Y, Nakamura S, Ueno M, Hagiya M, Hamuro J, et al. Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction. Sci Rep. 2016;6:26113. doi:10.1038/srep26113.
   PubMed Web of Science ®Google Scholar
• Okumura N, Ueno M, Koizumi N, Sakamoto Y, Hirata K, Hamuro J, Kinoshita S. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. Invest Ophthalmol Vis Sci. 2009;50(8):3680–87. doi:10.1167/iovs.08-2634.
   PubMed Web of Science ®Google Scholar
• Bostan C, Theriault M, Forget KJ, Doyon C, Cameron JD, Proulx S, Brunette I. In vivo functionality of a corneal endothelium transplanted by cell-injection therapy in a Feline model. Invest Ophthalmol Vis Sci. 2016;57(4):1620–34. doi:10.1167/iovs.15-17625.
   PubMed Web of Science ®Google Scholar
• Baum JL, Niedra R, Davis C, Yue BY. Mass culture of human corneal endothelial cells. Arch Ophthalmol. 1979;97(6):1136–40. doi:10.1001/archopht.1979.01020010590018.
   PubMedGoogle Scholar
• Joyce NC, Navon SE, Roy S, Zieske JD. Expression of cell cycle-associated proteins in human and rabbit corneal endothelium in situ. Invest Ophthalmol Vis Sci. 1996;37:1566–75.
   PubMed Web of Science ®Google Scholar
• Joyce NC, Meklir B, Joyce SJ, Zieske JD. Cell cycle protein expression and proliferative status in human corneal cells. Invest Ophthalmol Vis Sci. 1996;37:645–55.
   PubMed Web of Science ®Google Scholar
• Joyce NC, Harris DL, Zieske JD. Mitotic inhibition of corneal endothelium in neonatal rats. Invest Ophthalmol Vis Sci. 1998;39:2572–83.
   PubMed Web of Science ®Google Scholar
• Joyce NC. Proliferative capacity of the corneal endothelium. Prog Retin Eye Res. 2003;22(3):359–89. doi:10.1016/S1350-9462(02)00065-4.
   PubMed Web of Science ®Google Scholar
• Kikuchi M, Harris DL, Obara Y, Senoo T, Joyce NC. p27kip1 antisense-induced proliferative activity of rat corneal endothelial cells. Invest Ophthalmol Vis Sci. 2004;45(6):1763–70. doi:10.1167/iovs.03-0885.
   PubMed Web of Science ®Google Scholar
• Joyce NC. Cell cycle status in human corneal endothelium. Exp Eye Res. 2005;81(6):629–38. doi:10.1016/j.exer.2005.06.012.
   PubMed Web of Science ®Google Scholar
• Konomi K, Zhu C, Harris D, Joyce NC. Comparison of the proliferative capacity of human corneal endothelial cells from the central and peripheral areas. Invest Ophthalmol Vis Sci. 2005;46(11):4086–91. doi:10.1167/iovs.05-0245.
   PubMed Web of Science ®Google Scholar
• Kikuchi M, Zhu C, Senoo T, Obara Y, Joyce NC. p27kip1 siRNA induces proliferation in corneal endothelial cells from young but not older donors. Invest Ophthalmol Vis Sci. 2006;47(11):4803–09. doi:10.1167/iovs.06-0521.
   PubMed Web of Science ®Google Scholar
• Senoo T, Joyce NC. Cell cycle kinetics in corneal endothelium from old and young donors. Invest Ophthalmol Vis Sci. 2000;41:660–67.
   PubMed Web of Science ®Google Scholar
• Zhu C, Joyce NC. Proliferative response of corneal endothelial cells from young and older donors. Invest Ophthalmol Vis Sci. 2004;45(6):1743–51. doi:10.1167/iovs.03-0814.
   PubMed Web of Science ®Google Scholar
• Enomoto K, Mimura T, Harris DL, Joyce NC. Age differences in cyclin-dependent kinase inhibitor expression and rb hyperphosphorylation in human corneal endothelial cells. Invest Ophthalmol Vis Sci. 2006;47(10):4330–40. doi:10.1167/iovs.05-1581.
   PubMed Web of Science ®Google Scholar
• Mimura T, Joyce NC. Replication competence and senescence in central and peripheral human corneal endothelium. Invest Ophthalmol Vis Sci. 2006;47(4):1387–96. doi:10.1167/iovs.05-1199.
   PubMed Web of Science ®Google Scholar
• Kay ED, Cheung CC, Jester JV, Nimni ME, Smith RE. Type I collagen and fibronectin synthesis by retrocorneal fibrous membrane. Invest Ophthalmol Vis Sci. 1982;22:200–12.
   PubMed Web of Science ®Google Scholar
• Kim TY, Kim WI, Smith RE, Kay ED. Role of p27(Kip1) in cAMP- and TGF-beta2-mediated antiproliferation in rabbit corneal endothelial cells. Invest Ophthalmol Vis Sci. 2001;42(13):3142–49.
   PubMed Web of Science ®Google Scholar
• Lee HT, Kay EP. Regulatory role of PI 3-kinase on expression of Cdk4 and p27, nuclear localization of Cdk4, and phosphorylation of p27 in corneal endothelial cells. Invest Ophthalmol Vis Sci. 2003;44(4):1521–28. doi:10.1167/iovs.02-0637.
   PubMed Web of Science ®Google Scholar
• Lee HT, Lee JG, Na M, Kay EP. FGF-2 induced by Interleukin-1β through the action of phosphatidylinositol 3-kinase mediates endothelial mesenchymal transformation in corneal endothelial cells. J Biol Chem. 2004;279(31):32325–32. doi:10.1074/jbc.M405208200.
   PubMed Web of Science ®Google Scholar
• Lee JG, Kay EP. Two populations of p27 use differential kinetics to phosphorylate Ser-10 and Thr-187 via phosphatidylinositol 3-Kinase in response to fibroblast growth factor-2 stimulation. J Biol Chem. 2007;282(9):6444–54. doi:10.1074/jbc.M607808200.
   PubMed Web of Science ®Google Scholar
• Lee JG, Kay EP. Involvement of two distinct ubiquitin E3 ligase systems for p27 degradation in corneal endothelial cells. Invest Ophthalmol Vis Sci. 2008;49(1):189–96. doi:10.1167/iovs.07-0855.
   PubMed Web of Science ®Google Scholar
• Lee JG, Kay EP. PI 3-kinase/Rac1 and ERK1/2 regulate FGF-2-mediated cell proliferation through phosphorylation of p27 at Ser10 by KIS and at Thr187 by Cdc25A/Cdk2. Invest Ophthalmol Vis Sci. 2011;52(1):417–26. doi:10.1167/iovs.10-6140.
   PubMed Web of Science ®Google Scholar
• Hongo A, Okumura N, Nakahara M, Kay EP, Koizumi N. The effect of a p38 mitogen-activated protein kinase inhibitor on cellular senescence of cultivated human corneal endothelial cells. Invest Ophthalmol Vis Sci. 2017;58(9):3325–34. doi:10.1167/iovs.16-21170.
   PubMed Web of Science ®Google Scholar
• Okumura N, Nakano S, Kay EP, Numata R, Ota A, Sowa Y, Sakai T, Ueno M, Kinoshita S, Koizumi N. Involvement of cyclin D and p27 in cell proliferation mediated by ROCK inhibitors Y-27632 and Y-39983 during corneal endothelium wound healing. Invest Ophthalmol Vis Sci. 2014;55(1):318–29. doi:10.1167/iovs.13-12225.
   PubMed Web of Science ®Google Scholar
• Peh GS, Adnan K, George BL, Ang H-P, Seah X-Y, Tan DT, Mehta JS. The effects of Rho-associated kinase inhibitor Y-27632 on primary human corneal endothelial cells propagated using a dual media approach. Sci Rep. 2015;5:9167. doi:10.1038/srep09167.
   PubMed Web of Science ®Google Scholar
• Pipparelli A, Arsenijevic Y, Thuret G, Gain P, Nicolas M, Majo F, Connon CJ. ROCK inhibitor enhances adhesion and wound healing of human corneal endothelial cells. PLoS One. 2013;8(4):e62095. doi:10.1371/journal.pone.0062095.
   PubMed Web of Science ®Google Scholar
• Nakahara M, Okumura N, Nakano S, Koizumi N. Effect of a p38 mitogen-activated protein kinase inhibitor on corneal endothelial cell proliferation. Invest Ophthalmol Vis Sci. 2018;59(10):4218–27. doi:10.1167/iovs.18-24394.
   PubMed Web of Science ®Google Scholar
• Okumura N, Kusakabe A, Hirano H, Inoue R, Okazaki Y, Nakano S, Kinoshita S, Koizumi N. Density-gradient centrifugation enables the purification of cultured corneal endothelial cells for cell therapy by eliminating senescent cells. Sci Rep. 2015;5:15005. doi:10.1038/srep15005.
   PubMed Web of Science ®Google Scholar
• Okumura N, Kakutani K, Numata R, Nakahara M, Schlotzer-Schrehardt U, Kruse F, Kinoshita S, Koizumi N. Laminin-511 and −521 enable efficient in vitro expansion of human corneal endothelial cells. Invest Ophthalmol Vis Sci. 2015;56(5):2933–42. doi:10.1167/iovs.14-15163.
   PubMed Web of Science ®Google Scholar
• Okumura N, Kay EP, Nakahara M, Hamuro J, Kinoshita S, Koizumi N, Connon CJ. Inhibition of TGF-β signaling enables human corneal endothelial cell expansion in vitro for use in regenerative medicine. PLoS One. 2013;8(2):e58000. doi:10.1371/journal.pone.0058000.
   PubMed Web of Science ®Google Scholar
• Toda M, Ueno M, Hiraga A, Asada K, Montoya M, Sotozono C, Kinoshita S, Hamuro J. Production of homogeneous cultured human corneal endothelial cells indispensable for innovative cell therapy. Invest Ophthalmol Vis Sci. 2017;58(4):2011–20. doi:10.1167/iovs.16-20703.
   PubMed Web of Science ®Google Scholar
• Bartakova A, Kuzmenko O, Alvarez-Delfin K, Kunzevitzky NJ, Goldberg JL. A cell culture approach to optimized human corneal endothelial cell function. Invest Ophthalmol Vis Sci. 2018;59(3):1617–29. doi:10.1167/iovs.17-23637.
   PubMed Web of Science ®Google Scholar
• Sipp D. Hope alone is not an outcome: why regulations makes sense for the global stem cell industry. Am J Bioeth. 2010;10(5):33–34. doi:10.1080/15265161003754106.
   PubMed Web of Science ®Google Scholar
• Lysaght T, Campbell AV. Regulating autologous adult stem cells: the FDA steps up. Cell Stem Cell. 2011;9(5):393–96. doi:10.1016/j.stem.2011.09.013.
   PubMed Web of Science ®Google Scholar
• Bartakova A, Alvarez-Delfin K, Weisman AD, Salero E, Raffa GA, Merkhofer RM Jr., Kunzevitzky NJ, Goldberg JL, Identity N. Functional markers for human corneal endothelial cells. Invest Ophthalmol Vis Sci. 2016;57(6):2749–62. doi:10.1167/iovs.15-18826.
   PubMed Web of Science ®Google Scholar
• Cheong YK, Ngoh ZX, Peh GS, Ang H-P, Seah X-Y, Chng Z, Colman A, Mehta JS, Sun W. Identification of cell surface markers glypican-4 and CD200 that differentiate human corneal endothelium from stromal fibroblasts. Invest Ophthalmol Vis Sci. 2013;54(7):4538–47. doi:10.1167/iovs.13-11754.
   PubMed Web of Science ®Google Scholar
• Chng Z, Peh GS, Herath WB, Cheng TY, Ang H-P, Toh K-P, Robson P, Mehta JS, Colman A, Emanueli C. High throughput gene expression analysis identifies reliable expression markers of human corneal endothelial cells. PLoS One. 2013;8(7):e67546. doi:10.1371/journal.pone.0067546.
   PubMed Web of Science ®Google Scholar
• Frausto RF, Le DJ, Aldave AJ. Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell replacement therapy. Cell Transplant. 2016;25(6):1159–76. doi:10.3727/096368915X688948.
   PubMed Web of Science ®Google Scholar
• Ueno M, Asada K, Toda M, Hiraga A, Montoya M, Sotozono C, Kinoshita S, Hamuro J. MicroRNA profiles qualify phenotypic features of cultured human corneal endothelial cells. Invest Ophthalmol Vis Sci. 2016;57(13):5509–17. doi:10.1167/iovs.16-19804.
   PubMed Web of Science ®Google Scholar
• Ueno M, Asada K, Toda M, Nagata K, Sotozono C, Kosaka N, Ochiya T, Kinoshita S, Hamuro J. Concomitant evaluation of a panel of exosome proteins and MiRs for qualification of cultured human corneal endothelial cells. Invest Ophthalmol Vis Sci. 2016;57(10):4393–402. doi:10.1167/iovs.16-19805.
   PubMed Web of Science ®Google Scholar
• Ueno M, Asada K, Toda M, Schlotzer-Schrehardt U, Nagata K, Montoya M, Sotozono C, Kinoshita S, Hamuro J. Gene signature-based development of ELISA assays for reproducible qualification of cultured human corneal endothelial cells. Invest Ophthalmol Vis Sci. 2016;57(10):4295–305. doi:10.1167/iovs.16-19806.
   PubMed Web of Science ®Google Scholar
• Okumura N, Ishida N, Kakutani K, Hongo A, Hiwa S, Hiroyasu T, Koizumi N. Development of cell analysis software for cultivated corneal endothelial cells. Cornea. 2017;36(11):1387–94. doi:10.1097/ICO.0000000000001317.
   PubMed Web of Science ®Google Scholar
• Okumura N, Kobayashi K, Ishida N, Kagami T, Hiwa S, Hiroyasu T, Koizumi N. Development of cell analysis software to evaluate fibroblastic changes in cultivated corneal endothelial cells for quality control. Cornea. 2018;37(12):1572–78. doi:10.1097/ICO.0000000000001757.
   PubMed Web of Science ®Google Scholar
• Numa K, Tanaka H, Ueno M, Imai K, Hagiya M, Kitazawa K, Wakimasu K, Inatomi T, Okumura N, Koizumi N, et al. Four-year follow-up after injection of cultured corneal endothelial cells with a ROCK inhibitor for bullous keratopathy. Paper presented at: American Academy of Ophthalmology, 2019 Oct 12-15; San Francisco, USA; 2019.
   Google Scholar
• Shah RD, Randleman JB, Grossniklaus HE. Spontaneous corneal clearing after Descemet’s stripping without endothelial replacement. Ophthalmology. 2012;119(2):256–60. doi:10.1016/j.ophtha.2011.07.032.
   PubMed Web of Science ®Google Scholar
• Borkar DS, Veldman P, Colby KA. Treatment of Fuchs endothelial dystrophy by descemet stripping without endothelial keratoplasty. Cornea. 2016;35(10):1267–73. doi:10.1097/ICO.0000000000000915.
   PubMed Web of Science ®Google Scholar
• Iovieno A, Neri A, Soldani AM, Adani C, Fontana L. Descemetorhexis without graft placement for the treatment of fuchs endothelial dystrophy: preliminary results and review of the literature. Cornea. 2017;36(6):637–41. doi:10.1097/ICO.0000000000001202.
   PubMed Web of Science ®Google Scholar
• Moloney G, Petsoglou C, Ball M, Kerdraon Y, Hollhumer R, Spiteri N, Beheregaray S, Hampson J, DʼSouza M, Devasahayam RN. Descemetorhexis without grafting for fuchs endothelial dystrophy-supplementation with topical ripasudil. Cornea. 2017;36(6):642–48. doi:10.1097/ICO.0000000000001209.
   PubMed Web of Science ®Google Scholar
• Davies E, Jurkunas U, Pineda R 2nd. Predictive factors for corneal clearance after descemetorhexis without endothelial keratoplasty. Cornea. 2018;37(2):137–40. doi:10.1097/ICO.0000000000001427.
   PubMed Web of Science ®Google Scholar
• Garcerant D, Hirnschall N, Toalster N, Zhu M, Wen L, Moloney G. Descemetʼs stripping without endothelial keratoplasty. Curr Opin Ophthalmol. 2019;30(4):275–85. doi:10.1097/ICU.0000000000000579.
   PubMed Web of Science ®Google Scholar
• Macsai MS, Shiloach M. Use of topical Rho kinase inhibitors in the treatment of fuchs dystrophy after descemet stripping only. Cornea. 2019;38(5):529–34. doi:10.1097/ICO.0000000000001883.
   PubMed Web of Science ®Google Scholar
• Koizumi N, Okumura N, Ueno M, Nakagawa H, Hamuro J, Kinoshita S. Rho-associated kinase inhibitor eye drop treatment as a possible medical treatment for Fuchs corneal dystrophy. Cornea. 2013;32(8):1167–70. doi:10.1097/ICO.0b013e318285475d.
   PubMed Web of Science ®Google Scholar
• Okumura N, Koizumi N, Kay EP, Ueno M, Sakamoto Y, Nakamura S, Hamuro J, Kinoshita S. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing. Invest Ophthalmol Vis Sci. 2013;54:2493. doi:10.1167/iovs.12-11320.
   PubMed Web of Science ®Google Scholar